Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patientsCaterina Sagnelli, Francesca Rossi, Caterina Uberti‐Foppa et al.|PLoS ONE|2017Cited by 11
<i>In vivo</i>evidence that the cannabinoid receptor 2–63<scp>RR</scp>variant is associated with the acquisition and/or expansion of<scp>HIV</scp>infectionCaterina Sagnelli, Francesca Rossi, Caterina Uberti‐Foppa et al.|HIV Medicine|2018Cited by 7
Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective StudyM. Rinaldi, Maddalena Giannella, Davide Fiore Bavaro et al.|Open Forum Infectious Diseases|2025Cited by 1
Anti–Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes?Davide Fiore Bavaro, Michele Bartoletti, Alessandra Belati et al.|Clinical Infectious Diseases|2026Cited by 1
La terapia con i nuovi DAA in pazienti affetti da coinfezione HIV/HCV: esperienza di un centroDiletta Barbanotti, Caterina Uberti‐Foppa, Rossana Melzi et al.|JHA - Journal of HIV and Ageing|2017Cited by 0